• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Mount Sinai Deploys AI-Powered Clinical Trial-Matching Platform to Expand Access to Cancer Research

by Fred Pennic 01/08/2026 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Mount Sinai Deploys AI-Powered Clinical Trial-Matching Platform to Expand Access to Cancer Research

What You Should Know: 

– Mount Sinai Tisch Cancer Center has deployed PRISM, an AI-powered platform designed by Triomics for systemwide clinical trial matching.

– Utilizing OncoLLM—a large language model pipeline built specifically for oncology—PRISM identifies eligible patients across the entire Mount Sinai Health System (including Queens and Brooklyn) in real-time. 

– The strategic initiative aims to accelerate research enrollment and provide equitable access to cutting-edge treatments by replacing manual, time-intensive chart reviews with automated, oncology-specific intelligence.

Solving the “Fragmented Data” Dilemma in Oncology

Clinical trial matching has traditionally been a bottleneck in cancer research. It relies on a manual, time-intensive review of lengthy trial protocols against fragmented medical records, often leading to delays or missed opportunities.

PRISM (Powered by OncoLLM) addresses this by:

  • Oncology-Specific Reasoning: Unlike generic LLMs, OncoLLM is trained to understand the nuances of cancer care, from specific biomarkers to complex treatment histories.
  • Automated Eligibility Screening: The platform analyzes electronic health records (EHRs) to identify potentially eligible patients earlier and more consistently than manual review.
  • Equitable Access: By deploying the tool across the entire Mount Sinai Health System, the initiative democratizes access to cutting-edge treatments for diverse patient populations across NYC.

Integration with Epic and Oracle Health (Cerner)

Unlike generic LLMs, Triomics’ OncoLLM is built to sit natively within the EHR’s clinical data warehouse.

  • HL7 & FHIR Standards: PRISM utilizes Fast Healthcare Interoperability Resources (FHIR) to pull real-time patient demographics, pathology reports, and biomarker data directly from Epic or Oracle Health.
  • Unstructured Data Parsing: The “magic” of OncoLLM is its ability to read the “notes” section—where 80% of clinical trial inclusion/exclusion criteria often hide—and convert that text into structured data points.

The market is currently flooded with “AI wrappers,” but PRISM represents a shift toward domain-specific intelligence. In 2026, general-purpose LLMs are often flagged for hallucinations in high-stakes clinical settings. Triomics’ focus on an oncology-specific pipeline (OncoLLM) reflects the 12% of hospitals that have moved toward rigorous, specialized AI governance to ensure patient safety and data accuracy.

“Clinical trials are essential to advancing cancer care, but too often patients and their treating physicians are not aware of studies that may be appropriate for them,” said Karyn Goodman, MD, MS, Professor and Vice Chair of Clinical Research in the Department of Radiation Oncology at the Icahn School of Medicine at Mount Sinai and Associate Director of Clinical Research at TCC. “By deploying an AI platform trained specifically for oncology, we can identify trial opportunities earlier, more consistently, and more equitably, allowing clinicians to focus on meaningful conversations with patients rather than manual chart review.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Clinical Trials

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |